These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 11151264

  • 1. [Nonpreserved topical steroids and lacrimal punctal occlusion for severe keratoconjunctivitis sicca].
    Sainz De La Maza Serra M, Simón Castellvi C, Kabbani O.
    Arch Soc Esp Oftalmol; 2000 Nov; 75(11):751-756. PubMed ID: 11151264
    [Abstract] [Full Text] [Related]

  • 2. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome.
    Marsh P, Pflugfelder SC.
    Ophthalmology; 1999 Apr; 106(4):811-6. PubMed ID: 10201607
    [Abstract] [Full Text] [Related]

  • 3. Recurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren's syndrome.
    Hong S, Kim T, Chung SH, Kim EK, Seo KY.
    J Ocul Pharmacol Ther; 2007 Feb; 23(1):78-82. PubMed ID: 17341155
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of pressure topical anaesthesia in punctal occlusion by diathermy.
    Law RW, Li RT, Lam DS, Lai JS.
    Br J Ophthalmol; 2005 Nov; 89(11):1449-52. PubMed ID: 16234451
    [Abstract] [Full Text] [Related]

  • 5. Lacrimal punctum occlusion in the treatment of severe keratoconjunctivitis Sicca caused by Sjögren syndrome: a uniocular evaluation.
    Mansour K, Leonhardt CJ, Kalk WW, Bootsma H, Bruin KJ, Blanksma LJ, Sjögren Workgroup.
    Cornea; 2007 Feb; 26(2):147-50. PubMed ID: 17251802
    [Abstract] [Full Text] [Related]

  • 6. Punctal occlusion is safe and efficient for the treatment of keratoconjunctivitis sicca in patients with ocular GvHD.
    Sabti S, Halter JP, Braun Fränkl BC, Goldblum D.
    Bone Marrow Transplant; 2012 Jul; 47(7):981-4. PubMed ID: 22041848
    [Abstract] [Full Text] [Related]

  • 7. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation.
    Cordero-Coma M, Anzaar F, Sobrin L, Foster CS.
    Ocul Immunol Inflamm; 2007 Jul; 15(2):99-104. PubMed ID: 17558834
    [Abstract] [Full Text] [Related]

  • 8. Punctal plugs versus artificial tears for treating primary Sjögren's syndrome with keratoconjunctivitis SICCA: a comparative observation of their effects on visual function.
    Qiu W, Liu Z, Ao M, Li X, Wang W.
    Rheumatol Int; 2013 Oct; 33(10):2543-8. PubMed ID: 23649850
    [Abstract] [Full Text] [Related]

  • 9. Beneficial effect of topical fibronectin in patients with keratoconjunctivitis sicca of Sjögren's syndrome.
    Kono I, Matsumoto Y, Kono K, Ishibashi Y, Narushima K, Kabashima T, Yamane K, Sakurai T, Kashiwagi H.
    J Rheumatol; 1985 Jun; 12(3):487-9. PubMed ID: 4045849
    [Abstract] [Full Text] [Related]

  • 10. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.
    Lee HK, Ryu IH, Seo KY, Hong S, Kim HC, Kim EK.
    Ophthalmology; 2006 Feb; 113(2):198-205. PubMed ID: 16360211
    [Abstract] [Full Text] [Related]

  • 11. Punctal occlusion in the management of chronic Stevens-Johnson syndrome.
    Kaido M, Goto E, Dogru M, Tsubota K.
    Ophthalmology; 2004 May; 111(5):895-900. PubMed ID: 15121365
    [Abstract] [Full Text] [Related]

  • 12. Long-term follow-up of punctal and proximal canalicular stenoses after silicone punctal plug treatment in dry eye patients.
    Boldin I, Klein A, Haller-Schober EM, Horwath-Winter J.
    Am J Ophthalmol; 2008 Dec; 146(6):968-72.e1. PubMed ID: 18723140
    [Abstract] [Full Text] [Related]

  • 13. [Favourable effect of lacrimal plugs after 3 and 9 months in 20 patients with severe sicca syndrome].
    ter Borg EJ, Bistervels JH, Haanen HC.
    Ned Tijdschr Geneeskd; 2004 Dec 04; 148(49):2442-5. PubMed ID: 15626310
    [Abstract] [Full Text] [Related]

  • 14. SmartPlug versus silicone punctal plug therapy for dry eye: a prospective randomized trial.
    Burgess PI, Koay P, Clark P.
    Cornea; 2008 May 04; 27(4):391-4. PubMed ID: 18434839
    [Abstract] [Full Text] [Related]

  • 15. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
    Petrone D, Condemi JJ, Fife R, Gluck O, Cohen S, Dalgin P.
    Arthritis Rheum; 2002 Mar 04; 46(3):748-54. PubMed ID: 11920411
    [Abstract] [Full Text] [Related]

  • 16. Noninvasive interference tear meniscometry in dry eye patients with Sjögren syndrome.
    Uchida A, Uchino M, Goto E, Hosaka E, Kasuya Y, Fukagawa K, Dogru M, Ogawa Y, Tsubota K.
    Am J Ophthalmol; 2007 Aug 04; 144(2):232-237. PubMed ID: 17533107
    [Abstract] [Full Text] [Related]

  • 17. Topical cyclosporine A in severe steroid-dependent childhood phlyctenular keratoconjunctivitis.
    Doan S, Gabison E, Gatinel D, Duong MH, Abitbol O, Hoang-Xuan T.
    Am J Ophthalmol; 2006 Jan 04; 141(1):62-66. PubMed ID: 16386977
    [Abstract] [Full Text] [Related]

  • 18. [Flow cytometry in impression cytology during keratoconjunctivitis sicca: effects of topical cyclosporin A on HLA DR expression].
    Galatoire O, Baudouin C, Pisella PJ, Brignole F.
    J Fr Ophtalmol; 2003 Apr 04; 26(4):337-43. PubMed ID: 12843889
    [Abstract] [Full Text] [Related]

  • 19. Systemic sclerosis-associated Sjögren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients.
    Avouac J, Sordet C, Depinay C, Ardizonne M, Vacher-Lavenu MC, Sibilia J, Kahan A, Allanore Y.
    Arthritis Rheum; 2006 Jul 04; 54(7):2243-9. PubMed ID: 16802363
    [Abstract] [Full Text] [Related]

  • 20. Effects of topical human amniotic fluid and human serum in a mouse model of keratoconjunctivitis sicca.
    Quinto GG, Camacho W, Castro-Combs J, Li L, Martins SA, Wittmann P, Campos M, Behrens A.
    Cornea; 2012 Apr 04; 31(4):424-30. PubMed ID: 22290385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.